Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1982 Nov;35(11):1213–1215. doi: 10.1136/jcp.35.11.1213

Alpha-1-antitrypsin phenotypes in malignant lymphoma.

F Callea, G Massi, C De Wolf-Peeters, C Lievens, V J Desmet
PMCID: PMC497929  PMID: 6982905

Abstract

The alpha-1-antitrypsin (alpha 1 AT) Pi phenotypes have been determined by isoelectric focusing in a series of 228 patients having a histologically diagnosed malignant lymphoma and in 250 healthy controls. The Pi MZ phenotype occurred in 13 patients with lymphoma (5 . 8%) and in five of 250 healthy individuals (2%). Furthermore, one patient with a Pi SS and three patients with an abnormal unknown phenotype, migrating slower than Z, were found in the lymphoma group. No prevalence for a special lymphoma type was observed among the abnormal Pi phenotype patients. The increased incidence of abnormal Pi phenotypes in malignant lymphoma's support the hypothesis of the possible role of alpha 1 AT in development of immunopathological disorders.

Full text

PDF
1213

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ananthakrishnan R., Biegler B., Dennis P. M. Alpha 1-antitrypsin phenotypes in paraproteinaemias. Lancet. 1979 Mar 10;1(8115):561–562. doi: 10.1016/s0140-6736(79)90992-9. [DOI] [PubMed] [Google Scholar]
  2. Arora P. K., Miller H. C., Aronson L. D. alpha1-Antitrypsin is an effector of immunological stasis. Nature. 1978 Aug 10;274(5671):589–590. doi: 10.1038/274589a0. [DOI] [PubMed] [Google Scholar]
  3. Breit S. N., Penny R. The role of alpha 1 protease inhibitor (alpha 1 antitrypsin) in the regulation of immunologic and inflammatory reactions. Aust N Z J Med. 1980 Aug;10(4):449–453. doi: 10.1111/j.1445-5994.1980.tb04101.x. [DOI] [PubMed] [Google Scholar]
  4. ERIKSSON S. PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY. Acta Med Scand. 1964 Feb;175:197–205. doi: 10.1111/j.0954-6820.1964.tb00567.x. [DOI] [PubMed] [Google Scholar]
  5. Fagerhol M. K., Cox D. W. The Pi polymorphism: genetic, biochemical, and clinical aspects of human alpha 1-antitrypsin. Adv Hum Genet. 1981;11:1-62, 371-2. [PubMed] [Google Scholar]
  6. Kueppers F. Alpha-1-antitrypsin: physiology, genetics and pathology. Humangenetik. 1971;11(3):177–189. doi: 10.1007/BF00274738. [DOI] [PubMed] [Google Scholar]
  7. Massi G., Fabiano A., Ragusa D., Auconi P. Characterization of alpha-1-antitrypsin by isoelectric focusing on an ultrathin polyacrylamide gel layer. An economic high-resolution system for determining PiM subtypes. Hum Genet. 1979;53(1):91–95. doi: 10.1007/BF00289456. [DOI] [PubMed] [Google Scholar]
  8. Morse J. O. alpha1-antitrypsin deficiency (first of two parts). N Engl J Med. 1978 Nov 9;299(19):1045–1048. doi: 10.1056/NEJM197811092991905. [DOI] [PubMed] [Google Scholar]
  9. Morse J. O. alpha1-antitrypsin deficiency (first of two parts). N Engl J Med. 1978 Nov 9;299(19):1045–1048. doi: 10.1056/NEJM197811092991905. [DOI] [PubMed] [Google Scholar]
  10. Sharp H. L., Bridges R. A., Krivit W., Freier E. F. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med. 1969 Jun;73(6):934–939. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES